NIDC Program Literature

The National Isotope Development Center Product Catalog provides access to a comprehensive portfolio of radioactive and stable isotopes, enriched materials, and specialized production services supporting research, medicine, industry, national security, and emerging technologies. Managed by the U.S. Department of Energy Office of Isotope R&D and Production (IRP), the National Isotope Development Center connects customers with reliable isotope supplies, expert technical capabilities, and world-class production facilities to advance scientific discovery and innovation. Explore our catalog to find isotope products, technical specifications, availability information, and solutions tailored to your application needs. 

The U.S. Department of Energy Office of Isotope R&D and Production (DOE IRP) is the nation's leading source of critical radioactive and stable isotopes that support medical research, cancer therapies, quantum computing, fusion energy, national security, industrial applications, and scientific discovery. Through a nationwide network of national laboratories, universities, research reactors, particle accelerators, and isotope enrichment facilities, the program develops, produces, and distributes essential isotopes while strengthening America's domestic isotope supply chain. By advancing isotope research and partnering with industry to establish new commercial markets, the DOE IRP helps ensure reliable access to the materials that drive innovation, economic competitiveness, and technological leadership in the United States.

The routine use of radioisotopes in the fields of biology, medicine, and pharmaceuticals has led to safer and more effective diagnoses and treatments of numerous medical conditions, including cancer. As a result, millions of patients worldwide have experienced improved health and quality of life. Through its extensive network of national laboratories and partnering universities, the DOE IRP develops, produces, and supplies isotopes that are critical components of these medical diagnostic and treatment options. Particle accelerators, research reactors, medical cyclotrons, and radiochemical processing laboratories are among the facilities that help the program meet this objective.

The DOE IRP’s portfolio has grown over time to include more than 35 medically relevant isotopes available through the National Isotope Development Center (NIDC) product catalog, with several more under investigation at universities and national laboratories.